Back to Trades
Mazumdar Claire
Chief Executive OfficerDirectorCIK 0002034671
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 7
- Buy transactions
- 0
- Sell transactions
- 9
- Companies
- 2
- Active
- 2025–2026
Mazumdar Claire, Chief Executive Officer, Director, has filed 7 SEC reports (2025–2026), spread across 2 companies, totaling $4.0M in disclosed volume. Weighing $0 bought versus $2.2M sold, the history is heavily weighted toward selling. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
7 loaded
| Jul 14 | BCAX Bicara Therapeutics Inc. | Mazumdar Claire | Chief Executive Officer, Director | Sell | $284.2K |
| Jun 10 | RLAY Relay Therapeutics, Inc. | Mazumdar Claire | Insider | Award | $464.2K |
| Apr 20 | BCAX Bicara Therapeutics Inc. | Mazumdar Claire | Chief Executive Officer, Director | Sell | $354.1K |
| Mar 20 | BCAX Bicara Therapeutics Inc. | Mazumdar Claire | Chief Executive Officer, Director | Sell | $282.4K |
| Dec 18 | BCAX Bicara Therapeutics Inc. | Mazumdar Claire | Chief Executive Officer, Director | Exercise | $321.8K |
| Nov 25 | BCAX Bicara Therapeutics Inc. | Mazumdar Claire | Chief Executive Officer, Director | Sell | $776.4K |
| Oct 15 | BCAX Bicara Therapeutics Inc. | Mazumdar Claire | Chief Executive Officer, Director | Sell | $466.9K |
7 filings